Abstract

Converging evidence increasingly implicates shared etiologic and pathophysiological characteristics among major psychiatric disorders (MPDs), such as schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD). Examining the neurobiology of the psychotic-affective spectrum may greatly advance biological determination of psychiatric diagnosis, which is critical for the development of more effective treatments. In this study, ensemble clustering was developed to identify subtypes within a trans-diagnostic sample of MPDs. Whole brain amplitude of low-frequency fluctuations (ALFF) was used to extract the low-dimensional features for clustering in a total of 944 participants: 581 psychiatric patients (193 with SZ, 171 with BD, and 217 with MDD) and 363 healthy controls (HC). We identified two subtypes with differentiating patterns of functional imbalance between frontal and posterior brain regions, as compared to HC: (1) Archetypal MPDs (60% of MPDs) had increased frontal and decreased posterior ALFF, and decreased cortical thickness and white matter integrity in multiple brain regions that were associated with increased polygenic risk scores and enriched risk gene expression in brain tissues; (2) Atypical MPDs (40% of MPDs) had decreased frontal and increased posterior ALFF with no associated alterations in validity measures. Medicated Archetypal MPDs had lower symptom severity than their unmedicated counterparts; whereas medicated and unmedicated Atypical MPDs had no differences in symptom scores. Our findings suggest that frontal versus posterior functional imbalance as measured by ALFF is a novel putative trans-diagnostic biomarker differentiating subtypes of MPDs that could have implications for precision medicine.

Highlights

  • These authors contributed : Miao Chang, Fay Y

  • We performed analogous analyses on amplitude of low-frequency fluctuations (ALFF), cortical thickness, white matter integrity, polygenic risk scores (PRS), risk gene expression, and effects of medication status based on clinical diagnosis

  • A greater proportion of SZ appeared in Archetypal major psychiatric disorders (MPDs) (40%) than Atypical MPDs (16%)

Read more

Summary

Introduction

Clementz et al conducted a k-means clustering analysis of cognitive and electrophysiological measures using trans-diagnostic data generated from the Bipolar-Schizophrenia Network for Intermediate Phenotype consortium [7] They identified three “biotypes” that were largely orthogonal to the DSMIV diagnoses and significantly different with respect to external validating measures such as brain structure and function [9, 10]. Resting-state functional magnetic resonance imaging is well-established and has been widely performed for noninvasive exploration of the brain’s intrinsic functional architecture using measurements of spontaneous low-frequency fluctuations (LFFs) in the blood oxygenation level-dependent (BOLD) signal [13, 14] Their underlying mechanism is not exactly clear, LFFs appear to arise from neurovascular activity [15] and have been associated with glutamatergic/ GABAergic synaptic currents and glial activity [16, 17]. We examined the effects of medication status on symptom severity to elucidate possible pharmacologic effects within each of the subtypes

Methods
Results
Discussion
Limitations
Conclusion
Compliance with ethical standards
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.